» Articles » PMID: 38872816

Substance P - a Regulatory Peptide with Defense and Repair Functions. Results and Perspectives for the Fight Against COVID-19

Overview
Journal Front Neurol
Specialty Neurology
Date 2024 Jun 14
PMID 38872816
Authors
Affiliations
Soon will be listed here.
Abstract

Severe acute respiratory syndrome corona virus 2 (SARS CoV-2) is the cause of Corona virus disease 2019 (COVID-19), which turned into a pandemic in late 2019 and early 2020. SARS CoV-2 causes endothelial cell destruction and swelling, microthrombosis, constriction of capillaries, and malfunction of pericytes, all of which are detrimental to capillary integrity, angiogenesis, and healing processes. Cytokine storming has been connected to COVID-19 disease. Hypoxemia and tissue hypoxia may arise from impaired oxygen diffusion exchange in the lungs due to capillary damage and congestion. This personal view will look at how inflammation and capillary damage affect blood and tissue oxygenation, cognitive function, and the duration and intensity of COVID-19 disease. The general effects of microvascular injury, hypoxia, and capillary damage caused by COVID-19 in key organs are also covered in this point of view. Once initiated, this vicious cycle leads to diminished capillary function, which exacerbates inflammation and tissue damage, and increased inflammation due to hypoxia. Brain damage may result from low oxygen levels and high cytokines in brain tissue. In this paper we give a summary in this direction with focus on the role of the neuropeptide Substance P. On the basis of this, we discuss selected approaches to the question: "How Substance P is involved in the etiology of the COVID-19 and how results of our research could improve the prevention or therapy of corona? Thereby pointing out the role of Substance P in the post-corona syndrome and providing novel concepts for therapy and prevention.

References
1.
Samsam M, Covenas R, Ahangari R, Yajeya J, Narvaez J, Tramu G . Simultaneous depletion of neurokinin A, substance P and calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat during electrical stimulation of the trigeminal ganglion. Pain. 2000; 84(2-3):389-95. DOI: 10.1016/s0304-3959(99)00240-7. View

2.
Ho W, Douglas S . Substance P and neurokinin-1 receptor modulation of HIV. J Neuroimmunol. 2004; 157(1-2):48-55. DOI: 10.1016/j.jneuroim.2004.08.022. View

3.
Parameswaran K, Janssen L, OByrne P . Airway hyperresponsiveness and calcium handling by smooth muscle: a "deeper look". Chest. 2002; 121(2):621-4. DOI: 10.1378/chest.121.2.621. View

4.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

5.
Mazzone S, Geraghty D . Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists. Br J Pharmacol. 2000; 129(6):1121-31. PMC: 1571949. DOI: 10.1038/sj.bjp.0703172. View